TRCT
ELOS

Tower Research Capital (TRC)’s Syneron Medical Ltd ELOS Stock Holding History

Tower Research Capital (TRC)’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,683
Closed -$48K – 4518
2016
Q4 		$48K Sell
5,683
-8,998
-61% -$70.5K 0.01% 1463
2016
Q3 		$106K Buy
14,681
+11,272
+331% +$78.4K 0.01% 788
2016
Q2 		$26K Buy
+3,409
New +$24.3K ﹤0.01% 2049
2016
Q1 		– Sell
-392
Closed -$3K – 5512
2015
Q4 		$3K Sell
392
-2,593
-87% -$19.8K ﹤0.01% 3612
2015
Q3 		$22K Buy
2,985
+2,927
+5,047% +$28.1K ﹤0.01% 1668
2015
Q2 		$1K Buy
58
+21
+57% +$246 ﹤0.01% 4192
2015
Q1 		$0 Buy
37
+6
+19% +$66 ﹤0.01% 5289
2014
Q4 		$0 Buy
+31
New +$299 ﹤0.01% 5167
2014
Q3 		– Sell
-1,113
Closed -$11K – 5211
2014
Q2 		$11K Buy
1,113
+640
+135% +$6.92K ﹤0.01% 2316
2014
Q1 		$6K Sell
473
-2,393
-83% -$28.3K ﹤0.01% 3168
2013
Q4 		$35K Buy
2,866
+1,528
+114% +$15.9K 0.01% 1733
2013
Q3 		$12K Buy
1,338
+894
+201% +$7.72K ﹤0.01% 3112
2013
Q2 		$4K Buy
+444
New +$3.97K ﹤0.01% 3174

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tower Research Capital (TRC)'s ELOS Position: Q1 2017 in Review

Tower Research Capital (TRC) sold out of Syneron Medical Ltd (ELOS) in Q1 2017, closing a stake of 5,683 shares — an estimated $48K sold.

Tower Research Capital (TRC) first reported a position in ELOS in Q2 2013 and held it in 13 quarters. The position peaked at $106K in Q3 2016. 91 funds tracked by Wall St. Rank hold ELOS as of Q1 2017.

  • Tower Research Capital (TRC) reported no remaining Syneron Medical Ltd position as of Q1 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5,683 Syneron Medical Ltd shares in Q1 2017, an estimated $48K.
  • Tower Research Capital (TRC) first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s Syneron Medical Ltd position peaked at $106K in Q3 2016.
  • 91 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q1 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.